top of page

Acquiring a MIS Market Position​

Rumor has it Enovis is acquiring Novastep from Amplitude Surgical SAS, a public company listed on the Paris stock exchange. The gold nuggets for Enovis in the Novastep portfolio are the MIS portfolio and Fusionframe external fixation.

Novastep MIS portfolio?

MIS is a rapidly growing sector of the foot and ankle space and Novastep has a solid position. First launched in 2019, PECA implant systems for MIS bunion cuts and fixation underwent updates in 2021 with the launch of a guided instrumentation and implant platform PecaPlasty for percutaneous bunion correction.

Enovis is a player

With sales of $1.4 billion and growing at a robust 27.3%, annually, Enovis is ranked 6th among the largest orthopedic companies. Watch for its continued push in the foot and ankle space.

0 views0 comments

Recent Posts

See All

Cannabis sativa derivatives, or cannabinoids, are making their way into many of our pain strategies. Cannabidiol (CBD) is the most popular because of the lack of psychotropic effects. Deckey et al. fo

The 2023 American College of Foot & Ankle Surgeons (ACFAS) Annual Conference was last week in Los Angeles, CA. Here are some highlights, in case you missed it: New leadership. Dr. Eric Barp, DPM, FACF

Big Sky and AOFAS. The intimate setting of Big Sky, Montana hosted the AOFAS winter meeting last month. Designed as a smaller meeting in a family-friendly location this year featured massive amounts o

FIX Masthead 2000x318 v2.jpg
bottom of page